Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117040) titled 'Clinical Application and Optimization Strategies of Rh Blood Group Compatibility Transfusion in Patients with Transfusion-Dependent Thalassemia in Liuzhou City' on Jan. 19.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Liuzhou Worker's Hospital
Condition:
Transfusion-Dependent Thalassemia (TDT)
Intervention:
Control group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Control group:100;Observation group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?pro...